Idera Pharmaceuticals reported $54.34M in Market Capitalization for its third fiscal quarter of 2021.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Market Capitalization Change
Abbott ABT:US $ 209.42B 3.44B
Aceto ACET:US $ 249.64M 77.72M
Agenus AGEN:US $ 1.22B 2.65M
Alnylam Pharmaceuticals ALNY:US $ 22.44B 2.51B
Amgen AMGN:US $ 120.75B 19.29B
Biogen BIIB:US $ 42.17B 9.96B
Biomarin Pharmaceutical BMRN:US $ 14.17B 1.08B
Cytrx CYTR:US 22.59M 13.85M
Dynavax Technologies DVAX:US $ 2.2B 1.08B
Eli Lilly And LLY:US $ 221.02B 902.49M
Gilead Sciences GILD:US $ 87.58B 1.22B
GlaxoSmithKline GSK:LN 70.63B 794.04M
Idera Pharmaceuticals IDRA:US $ 54.34M 5.7M
Merk MRK:US $ 190131.55M 6786.63M
Mirati Therapeutics MRTX:US $ 9.13B 823.57M
Nektar Therapeutics NKTR:US $ 3.3B 172.65M
Pfizer PFE:US $ 241143.67M 21937.97M
Sarepta Therapeutics SRPT:US $ 7.38B 1.18B
Seattle Genetics SGEN:US $ 30.89B 2.24B
Ultragenyx Pharmaceutical RARE:US $ 6.12B 316.34M
X T L Biopharmaceuticals XTLB:US 15.7M 6.23M